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We have previously shown that aB-crystallin (CRYAB), a small heat shock protein (sHsp) that prevents
irreversible aggregation of unfolded protein by an ATP-independent chaperone activity, plays a pivotal
role in the biogenesis of multipass transmembrane proteins (TMPs) assisting their folding from the
cytosolic side of the endoplasmic reticulum (ER) (D'Agostino et al., 2013). Here we present evidence,
based on phosphomimetic substitutions, that the three phosphorytable serine residues at position 19, 45
and 59 of CRYAB play a different regulatory role in this novel chaperone activity: S19 and S45 have a
strong inhibitory effect, either alone or in combination, while S59 has not and counteracts the inhibition
caused by single phosphomimetic substitutions at S19 and S45. Interestingly, all phosphomimetic sub-
stitutions determine the formation of smaller oligomeric complexes containing CRYAB, indicating that
the inhibitory effect seen for S19 and S45 cannot be ascribed to the reduction of oligomerization
frequently associated to a decreased chaperone activity. These results indicate that phosphorylation
ﬁnely regulates the chaperone activity of CRYAB with multipass TMPs and suggest a pivotal role for S59
in this process.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
CRYAB is member of the sHsp family endowed of ATP-
independent chaperone activity [1e5]. It is a 175-residues poly-
peptide that assembles into polydisperse and dynamic protein
complexes ranging between 200 and 1000 kDa [2,4,6]. The protein
consists of an N-terminal domain, a conserved central a-crystallin
domain and a short C-terminal domain [4,7]. It forms soluble
complexes with partially unfolded proteins preventing them from
irreversible aggregation (“holdase” activity) and keeping them
ready for the function of other chaperones that assist in the folding
[8]. Besides the crucial role made in the lens in associationwith aA-
crystallin [3], CRYAB is an extensively expressed sHsp that play asmic reticulum; TMP, trans-
etinopathy; MAPK, mitogen-
ein.
y, University of Lausanne,
r Inc. This is an open access articlerole in a variety of cellular functions such as cell cycle, differenti-
ation, apoptosis, gene expression and has been associated with
several pathological conditions [9e14]. This variety of functions
most likely relies upon structural and functional changes, largely
depending on post translational modiﬁcations [15]. A major role in
CRYAB function is played by phosphorylation occurring at three
serine residues at positions 19, 45 and 59 of the N-terminal domain
[16,17]. S45 (and possibly S19) is phosphorylated by ERK1/2 and
S59 by p38-mitogen-activated protein kinase (MAPK) [16,18,19].
The effect of phosphorylation of these serines on the chaperone
activity of CRYAB is disputed, and several examples of increased as
well as decreased activity have been reported [15,17,19e24]. It is
agreed that phosphorylation (or pseudo-phosphorylation) leads to
the formation of smaller oligomeric complexes that exhibit higher
dynamic of subunit exchange and several reports ascribe the
decreased chaperone activity to the smaller size of the oligomers
[23e25]. In contrast, it has been proposed that phosphorylation-
dependent induction of small oligomeric structure enhanced
CRYAB chaperone activity by increasing binding afﬁnity for target
proteins [17,26]. In particular, it was shown that phosphorylation
increases the rate of CRYAB subunit exchange inﬂuencing its ﬂex-
ibility and determining structural changes that lead to expose moreunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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tivity. Therefore, phosphorylation impacts CRYAB structure and
function in a complex fashion.
We have recently reported that CRYAB assists the folding of
multipass transmembrane proteins from the cytosolic face of the
ER. It binds and prevents the oligomerization-dependent retention
in the ER of ATP7B-H1069Q, a mutant form of the copper trans-
porter associated to the Wilson disease, and of Frizzled4-
L501fsX533, a frame-shift mutant associated to a rare form of Fa-
milial exudative vitreoretinopathy (FZ4-FEVR) [27]. In both in-
stances, the mutated proteins accumulate in the ER and are not
transported to their ﬁnal destination (trans-Golgi network and
plasmamembrane, respectively), but in the presence of CRYAB they
rescue proper folding and localization, and the rescued ATP7B-
H1069Q moves to post-Golgi locations in response to copper
overload similarly to the wild-type counterpart [27]. Notably, even
endogenous level of CRYAB were sufﬁcient to rescue overexpressed
ATP7B-H1069Q to the trans-Golgi [27]. Thus, given the interesting
therapeutic perspectives opened by these ﬁndings, in particular for
theWilson disease, we askedwhether phosphorylation of the three
serine residues of CRYAB would affect this chaperone activity to-
wards misfolded multipass TMPs. Our results, obtained with
phosphomimetic substitutions, show that phosphorylation of S19
and S45 has a clear inhibitory effect while phosphorylation of S59
has not. Intriguingly, the latter protects the chaperone activity from
the partial phosphorylation of the other reesidues, while in all in-
stances the size of the oligomeric complexes containing CRYAB is
decreased.
2. Material and methods
2.1. Reagents
All reagents for cells culture were from Gibco Life Technologies,
Grand Island, U.S.A.; Corning, Manassas, U.S.A,; Lonza, Verviers,
Belgium. Solid chemicals and liquid reagents were from Sigma-
Aldrich, Milan, Italy; Bio-Rad, Segrate, Italy; Roche, Indianalpolis,
U.S.A.; Promega, Madison, U.S.A.
2.2. Antibodies
The following antibodies were used: mouse monoclonal anti-
HA, rabbit polyclonal anti-HA, mouse monoclonal anti-FLAG and
rabbit polyclonal anti-Golgin (GOLGA2) from Sigma Aldrich, Milan,
Italy); mouse monoclonal anti-CRYAB (Enzo Life Sciences, Rome,
Italy); Alexa Fluor-conjugated goat anti-mouse and anti-rabbit IgG
(Termo Fisher Scientiﬁc, U.S.A); HRP-conjugated goat anti-mouse
and anti-rabbit IgG for immunoblotting (Santa Cruz Biotech-
nology, Dallas, U.S.A.
2.3. cDNA cloning and plasmid construction
See supplementary material.
2.4. Cell culture, transfection, immunoﬂuorescence and
sedimentation analysis in glycerol gradient
All performed as previously detailed [27].
2.5. Preparation of cell extracts, SDS-PAGE and western
immunoblotting
Preparation of cell extracts, SDS-PAGE, and western immuno-
blotting were performed as previously detailed [28].3. Results
3.1. Mutagenesis
In order to investigate the role of phosphorylation in the
chaperone function of CRYAB toward misfolded multipass TMPs,
we substituted the relevant serine residues with aspartic acid. This
is awidely used tool to mimic serine-phosphorylation of protein for
performing functional studies with CRYAB as well as many other
proteins [23]. As shown in Fig. S1, the serine residues in position 19,
45 and 59 were all substituted with aspartic acid (CRYAB-S3D) or
with alanine residues (CRYAB-S3A) to prevent phosphorylation. In
addition, CRYAB-S3A construct was further mutagenized to
generate either the single pseudo-phosphorylated CRYAB-S19D,
-S45D and -S59D mutants or the double pseudo-phosphorylated
CRYAB-S19/45D, -S19/59D and -S45/59D to ascertain the func-
tional contribution of each phosphomimetic residue or of couple of
residues, having prevented phosphorylation at the other relevant
serines. Finally, as a negative control for CRYAB activity, we
generated and used throughout this study the mutant CRYAB-
R120G that binds to the client proteins but is largely defective in
the chaperone activity [29].
3.2. Effect of serine pseudo-phosphorylation on CRYAB chaperone
function
We have previously shown that CRYAB, but not CRYAB-R120G, is
able to rescue the localization to the Golgi complex of the mutant
copper transporter ATP7B-H1069Q expressed in transfected cells
[27]. This mutant accumulates in the ER, presumably as the result of
misfolding, and has a shorter half-life [30]. Confocal immunoﬂuo-
rescence microscopy of transfected COS-7 cells allowed to evi-
dentiate the mislocalization of ATP7B-H1069Q in comparison of
ATP7B, whose great majority resides in the Golgi complex (besides
a minority in putative post-Golgi locations, Fig. 1A,B and Fig. S2).
When CRYAB or CRYAB-S3A, -S3D or -R120G mutants were co-
transfected with ATP7B-H1069Q, a clear-cut result was obtained:
CRYAB-S3Awas as good as CRYAB in rescuing the localization of the
mutant transporter (Fig. 1C,E and Fig. S2), while CRYAB-S3D
showed only residual rescuing activity, close to the inactive
mutant -R120G (Fig. 1D,F and Fig. S2). Next, we asked whether the
three serines could equally and/or additively contribute to the
negative regulation of chaperone activity seen for the -S3D mutant.
Intriguingly, the two pseudo-phosphorylated CRYAB-S19D and
-S45D single mutants showed only residual activity (Fig. 1G,H and
Fig. S2), while the -S59D mutant resulted fully active (Fig. 1I and
Fig. S2). Co-immunoprecipitation experiments indicated that
phosphomimetic S19, S45, S59 and S3D, as well as R120G, bind to
ATP7B-H1069Q (data not shown) [27], thus the lack of activity
could not be ascribed to loss of binding. Therefore, these results
strongly suggested that phosphorylation at the three serine resi-
dues differently inﬂuences CRYAB chaperone activity toward
ATP7B-H1069Q in living cells.
Next, in order to generalize the results obtained, we performed
the same experimental design using the mutant FZ4-FEVR receptor
instead of ATP7B-H1069Q. In this mutant, a frameshift mutation
(L501fsX533) generates a different and shorter C-terminal cytosolic
tail of the receptor that accumulates in the ER of transfected cells
[31], not reaching the plasma membrane as FZ4 wild-type. This
mutation is associated to a very rare dominant form of Familiar
exudative vitreoretinopathy (FEVR) through a molecular mecha-
nism not clariﬁed yet [32,33]. In previous work we demonstrated
that FZ4-FEVR aggregated in the ER forming not-native inter-chain
disulﬁde bridges [34], but the overexpression of CRYAB prevented
aggregation and allowed plasma membrane localization of this
Fig. 1. CRYAB-S59D restores ATP7B-H1069Q localization in the Golgi complex while CRYAB-S19D, CRYAB-S45D and the triple pseudo-phosphorylated CRYAB-S3D do not. Parallel
cultures of COS-7 cells grown on coverslips were co-transfected to express the indicated GFP-ATP7B forms (ﬁrst column on the left) and the indicated 3xFLAG-tagged CRYAB forms
or the control empty vector (second column from the left). 48 h post-transfection the cells were processed for confocal immunoﬂuorescence microscopy. The anti-Golgin polyclonal
Golga2 antibody was used to visualize the Golgi complex (third column from the left). Colocalization of GFP and Golga2 signals was determined with the ImageJ colocalization
plugin and the obtained Pearson's R value is shown on the right (mean ± s.d., n. ¼ 10 cells of randomly selected ﬁelds from two independent experiments). Scale bar: 10 mm.
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Fig. 2. The pseudo-phosphorylated S59D protects CRYAB chaperone activity in double pseudo-phosphorylated mutants. Cells were manipulated and analyzed as in Fig. 1.
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and only background level of FZ4-FEVRwas localized on the surface
of Huh-7 transfected cells. As expected, in the presence of CRYAB,
FZ4-FEVR was almost fully rescued at the plasma membrane
(Fig. S3C). In contrast, only a minor rescue was detected when
CRYAB-S3D, -S19D or -S45D substituted CRYAB (Fig. S3E-G), while
both CRYAB-S3A and -S59D had a strong rescue effect, only slightly
below the wild-type (Fig. S3D,H). Thus, these results fully
conﬁrmed those obtained with ATP7B-H1069Q, clearly suggesting
that phosphorylation results in a differential control of CRYAB
chaperone activity toward multipass TMPs.3.3. Chaperone activity of CRYAB double pseudo-phosphorylated
mutants
Since CRYAB serine residues are phosphorylated by kinases
downstream to different signaling pathways [19,24] that could
differently control the ﬁnal phosphorylation pattern of CRYAB, weasked whether different combinations of pseudo-phosphorylation
could differently inﬂuence CRYAB chaperone activity. To this end,
we generated double pseudo-phosphorylated mutants of CRYAB
(Fig. S1) that were assayed for chaperone activity by co-transfection
with the ATP7B-H1069Q mutant. As shown in Figs. 2D and Fig. S2,
the S19/45D resulted almost not active, while both S19/59D and
S45/59D (Fig. 2E,F and Fig. S2) were close to the full active CRYAB
control (COS-7 cells. and Fig. S2). These results support the exclu-
sive inhibitory role of pseudo-phosphorylated serines 19 and 45,
but also indicate that pseudo-phosphorylation at S59 has an
interesting protective effect toward single pseudo-phosphorylation
of either S19 or S45, but not of both residues at the same time.3.4. Pseudo-phosphorylation decreases the size of the oligomeric
complex containing CRYAB in transfected cells
It has been previously reported that CRYAB chaperone activity,
similarly to Hsp27, is directly proportional to the size of its
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pacts the oligomerization state of these chaperones, thus suggest-
ing an indirect link between phosphorylation and chaperone
activity [15]. For this reason, we asked whether the different
contribution of phosphorylated serines for the chaperone activity
could be due to a different impact on the oligomerization state of
the chaperone. To this end, cells were transiently transfected with
different phosphomimetic mutants and cell lysates were analyzed
by sedimentation assay in glycerol gradient, SDS-PAGE and
immunoblotting. As shown in Fig. S4, almost 2/3 of total CRYAB
sedimented in the heavier region of the gradient, as well as CRYAB-
R120G. Interestingly, CRYAB-S3D was slightly enriched in the
lighter region while CRYAB-S3A was equally present in the two
regions. Most importantly, all three single pseudo-phosphorylated
mutants -S19D, -S45D and -S59D were clearly enriched in the
lighter fractions. Thus, both the results observed with CRYAB-S3D
and -S3A, and primarily the ﬁnding that CRYAB-S59D forms small
oligomeric complexes although is endowed of almost full chap-
erone activity, do not support the simple correlation between loss
of activity and reduced oligomerization. In conclusion, these results
indicate that phosphorylation has a direct role in the regulation of
CRYAB chaperone activity besides its role in the regulation of the
oligomeric state of the chaperone.
4. Discussion
In this work we provide compelling evidences that in living cells
phosphorylation plays an important role in the regulation of the
chaperone activity of CRYAB to correct mislocalization of two
disease-associated multipass TMPs. Mimicking phosphorylation of
serine 19 and 45, either singularly or in combination, causes a
pronounced reduction of CRYAB chaperone activity, while the sin-
gle phosphomimetic S59 has no such effect. On the other hand,
pseudo-phosphorylation on serine 59 prevents the 19/45
phosphorylation-dependent inhibitory effect, but this protecting
effect is lost when all three serine residues are simultaneously
pseudo-phosphorylated. Interestingly, the inhibition of chaperone
activity does not correlate with the reduction of the oligomeriza-
tion state of CRYAB, suggesting a direct role of phosphorylation in
controlling CRYAB chaperone activity. In conclusion, our work
demonstrates that phosphorylation of the serine residues 19, 45
and 59 ﬁnely regulates the chaperone activity of CRYAB with
multipass TMPs and suggests a pivotal role for S59 in this process.
How does phosphorylation control CRYAB chaperone activity?
As previously reported, CRYAB can use its structural plasticity to
expose different binding interfaces [35,36]. Indeed, in a proteomic
study using HeLa cells subjected to heat stress, more than 300
proteins belonging to the heat-sensitive fraction of the proteome
have been found to be protected from aggregation by CRYAB,
indicating a rather promiscuous binding [26]. However, some
proteins, like caspase-3 or Bax, that were shown to interact with
CRYAB in physiological condition [37], have not been found in this
interactome suggesting that stress conditions and/or extracellular
stimuli may inﬂuence the speciﬁcity of CRYAB binding/chaperone
activity [26]. On line with this observation, we speculate that
phosphorylation controls CRYAB conformational state and plas-
ticity so that changes of the phosphorylation pattern may differ-
ently change CRYAB activity. Accordingly, the phosphorylation
pattern that inhibits chaperone activity of CRYAB for FZ4-FEVR and
ATP7B-H1069Q (S19D, S45D, S19/45D, or 3D) has been previously
reported to reduce its activity to prevent amyloid ﬁber formation of
ccb-Trp peptide but not of k-casein where the same pattern was
shown to confer higher protection [23]. Thus, the phosphorylation
of CRYAB has a different effect according to the aggregation prone
protein engaged. Thereby, aside its role in the regulation of CRYABoligomeric size, phosphorylation plays an important role in con-
trolling the activity and perhaps the targeting of this chaperone.
Does CRYAB phosphorylation play a role in the unfolded protein
response (UPR) triggered by accumulation in the ER of multipass
TMPs?
Recent ﬁndings have shown thatMAPK signaling pathways have
a fundamental role in the response to ER stress and UPR [38]. All
three canonical MAPKs (ERK1/2, JNK and p38) are known to be
activated with different kinetics and with different roles [38].
Indeed, the MAPK signaling network is known to regulate either
cell cycle progression and survival or cell death [39e41]. Among
them, ERK1/2 and p38 signaling pathways seem to have a relevant
role in the regulation of several cytosolic HSPs including CRYAB
[42e44]. Particularly, serine 45 (and possibly serine 19) is phos-
phorylated by ERK1/2 while serine 59 by p38 dependent MAPK
[19]. Interestingly, p38 MAPK down-regulates ERK1/2 [45] sug-
gesting that phosphorylation on serine 59 is followed by a negative
regulation of the phosphorylation of serine 19 and 45. Thus, the
protective role shown in the present paper of phosphomimetic S59
when CRYAB is also pseudo-phosphorylated at position 19 or 45
would reinforce the negative regulation of ERK1/2. Interestingly, it
has been reported that overexpression of ATP7B-H1069Q in HEP-
G2 cells activates p38, and the total level of ATP7B-H1069Q and
the amount able to fold and reach the trans-Golgi network increase
when the cells are incubated with inhibitors of p38 [46]. However,
CRYAB is minimally expressed in hepatocytes and hepatoma cell
lines [47e49], as conﬁrmed by the comprehensive proteomic
analysis performed to determine the interactome of ATP7B-
H1069Q transfected in HEP-G2 cells that failed to reveal CRYAB
[46]: thus, most likely, p38 does not hit CRYAB in HEP-G2 cells.
Most interestingly, p38 kinase activity is required for the phos-
phorylation dependent nuclear translocation of the spliced form of
Xbp1s [50]. This protein is produced during the UPR, which nor-
mally occurs when unfolded proteins accumulate in the ER.
Because multipass TMPs expose domains on either the luminal as
well as the cytosolic side of the ER, mutations affecting their folding
and export from the ER most likely require the coordinated acti-
vation of chaperones acting from both sides of the ER membrane.
Indeed, the MAPK signaling pathway may provide this coordina-
tion, participating to the UPR to generate the response in the lumen
and protecting, at the same time, the cytosolic chaperone activity of
CRYAB to assist misfolded multipass TMPs.
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